These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8844655)

  • 21. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae.
    Nicoletti C; Yang X; Cerny J
    J Immunol; 1993 Jan; 150(2):543-9. PubMed ID: 8419487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamarin model of pneumococcal bacteremia.
    Chudwin DS; Artrip SG; Ogden JD; Schiffman G
    J Med Primatol; 1987; 16(4):249-60. PubMed ID: 3114496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
    Coats MT; Benjamin WH; Hollingshead SK; Briles DE
    Vaccine; 2005 Jul; 23(33):4257-62. PubMed ID: 16005736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae.
    Cui Y; Zhang X; Gong Y; Niu S; Yin N; Yao R; Xu W; Li D; Wang H; He Y; Cao J; Yin Y
    Vaccine; 2011 Feb; 29(9):1736-44. PubMed ID: 21238570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.
    Nicoletti C
    Exp Mol Pathol; 1995 Apr; 62(2):99-108. PubMed ID: 8549700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.
    Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM
    Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody and splenocyte proliferation response to whole inactivated Streptococcus pneumoniae serotype 1, 3 and 6B in mice.
    Pană M; Orhan R; Bănică L; Iancu AD; Stăvaru C
    Roum Arch Microbiol Immunol; 2011; 70(4):168-73. PubMed ID: 22568264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against pneumococcal C-polysaccharide are not protective.
    Nielsen SV; Sørensen UB; Henrichsen J
    Microb Pathog; 1993 Apr; 14(4):299-305. PubMed ID: 8326853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of TEPC-183 plasmacytoma on resistance of passively or actively immunized BALB/c mice to infection with Streptococcus pneumoniae.
    Havas HF; Schiffman G; Schmitz J
    Cancer Res; 1984 Aug; 44(8):3299-302. PubMed ID: 6744264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB; Carter AT; Hitchin E; Wells JM
    J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.
    Jokinen JT; Ahman H; Kilpi TM; Mäkelä PH; Käyhty MH
    J Infect Dis; 2004 Aug; 190(3):545-50. PubMed ID: 15243930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
    McDaniel LS; Benjamin WH; Forman C; Briles DE
    J Immunol; 1984 Dec; 133(6):3308-12. PubMed ID: 6491288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
    Scand J Immunol; 2009 Mar; 69(3):194-202. PubMed ID: 19281531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice.
    Khan MN; Bansal A; Shukla D; Paliwal P; Sarada SK; Mustoori SR; Banerjee PK
    Vaccine; 2006 Sep; 24(37-39):6225-31. PubMed ID: 16797798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pectic polysaccharides isolated from Malian medicinal plants protect against Streptococcus pneumoniae in a mouse pneumococcal infection model.
    Inngjerdingen KT; Langerud BK; Rasmussen H; Olsen TK; Austarheim I; Grønhaug TE; Aaberge IS; Diallo D; Paulsen BS; Michaelsen TE
    Scand J Immunol; 2013 May; 77(5):372-88. PubMed ID: 23611658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3.
    Fine DP; Kirk JL; Schiffman G; Schweinle JE; Guckian JC
    J Lab Clin Med; 1988 Oct; 112(4):487-97. PubMed ID: 3171357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.